Immuron Limited
IMRN
$0.71
-$0.04-5.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.52% | 2.29% | 25.65% | 23.30% | 69.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.52% | 2.29% | 25.65% | 23.30% | 69.54% |
| Cost of Revenue | 15.29% | 11.76% | 45.59% | 42.92% | 72.49% |
| Gross Profit | 0.60% | -2.48% | 16.68% | 14.49% | 68.10% |
| SG&A Expenses | -1.32% | -4.35% | 1.52% | -0.39% | 43.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 47.91% | 49.52% | 55.55% | 56.38% | 62.75% |
| Total Operating Expenses | -5.07% | -7.97% | 3.43% | 1.49% | 49.29% |
| Operating Income | 21.72% | 24.10% | 14.28% | 15.88% | -25.68% |
| Income Before Tax | 22.33% | 24.71% | 45.49% | 46.51% | -20.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 22.33% | 24.71% | 45.49% | 46.51% | -20.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.33% | 24.71% | 45.49% | 46.51% | -20.03% |
| EBIT | 21.72% | 24.10% | 14.28% | 15.88% | -25.68% |
| EBITDA | 22.00% | 24.38% | 14.43% | 15.93% | -24.76% |
| EPS Basic | 34.29% | 36.11% | 47.14% | 47.14% | -16.67% |
| Normalized Basic EPS | 36.36% | 39.13% | 41.03% | 41.03% | -15.79% |
| EPS Diluted | 34.29% | 36.11% | 47.14% | 47.14% | -16.67% |
| Normalized Diluted EPS | 36.36% | 39.13% | 41.03% | 41.03% | -15.79% |
| Average Basic Shares Outstanding | 19.91% | 19.91% | 2.38% | 2.38% | 0.32% |
| Average Diluted Shares Outstanding | 19.91% | 19.91% | 2.38% | 2.38% | 0.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |